The DOI matches its Crossref record.
Urine Podocyte mRNAs Mark Progression of Renal Disease
Open accessAbstract
Because loss of podocytes associates with glomerulosclerosis, monitoring podocyte loss by measuring podocyte products in urine may be clinically useful. To determine whether a single episode of podocyte injury would cause persistent podocyte loss, we induced limited podocyte depletion using a diphtheria toxin receptor (hDTR) transgenic rat. We monitored podocyte loss by detecting nephrin and podocin mRNA in urine particulates with quantitative reverse transcriptase-PCR. Aquaporin 2 mRNA served as a kidney reference gene to account for variable kidney contribution to RNA amount and quality. We found that a single injection of diphtheria toxin resulted in an initial peak of proteinuria and podocyte mRNAs (podocin and nephrin) followed 8 d later by a second peak of proteinuria and podocyte mRNAs that were podocin positive but nephrin negative. Proteinuria that persisted for months correlated with podocin-positive, nephrin-negative mRNAs in urine. Animals with persistent podocyte mRNA in urine progressed to ESRD with global podocyte depletion and interstitial scarring. Podocytes in ectatic tubules expressed podocalyxin and podocin proteins but not nephrin, compatible with detached podocytes' having an altered phenotype. Parallel human studies showed that biopsy-proven glomerular injury associated with increased urinary podocin:aquaporin 2 and nephrin:aquaporin 2 molar ratios. We conclude that a single episode of podocyte injury can trigger glomerular destabilization, resulting in persistent podocyte loss and an altered phenotype of podocytes recovered from urine. Podocyte mRNAs in urine may be a useful clinical tool for the diagnosis and monitoring of glomerular diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Focal Segmental Glomerulosclerosis
D'Agati, V. D., Kaskel, F. J., & Falk, R. J. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1106556 · Cited by 825
Renal fibrosis: novel insights into mechanisms and therapeutic targets
Boor, P., Ostendorf, T., & Floege, J. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.120 · Cited by 606
Defining cell-type specificity at the transcriptional level in human disease
Ju, W., Greene, C. S., Eichinger, F., Nair, V., Hodgin, J. B., Bitzer, M., Lee, Y.-S., Zhu, Q., Kehata, M., Li, M., et al. (2013) · Genome Research · doi:10.1101/gr.155697.113 · Cited by 252
Self-citationTargeting mTOR Signaling Can Prevent the Progression of FSGS
Zschiedrich, S., Bork, T., Liang, W., Wanner, N., Eulenbruch, K., Munder, S., Hartleben, B., Kretz, O., Gerber, S., Simons, M., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016050519 · Cited by 76
Metadata
- Authors
- Sato, Y., Wharram, B. L., Lee, S. K., Wickman, L., Goyal, M., Venkatareddy, M., Chang, J. W., Wiggins, J. E., Lienczewski, C., Kretzler, M., & Wiggins, R. C.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2009-05
- Volume
- 20
- Issue
- 5
- Pages
- 1041-1052
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2102989684
- Cited by
- 160
- References
- 0
- FWCI
- 8.45
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Urine Podocyte mRNAs Mark Progression of Renal Disease. https://app.cochat.ai/papers/10.1681/asn.2007121328
- The paper
- Sato, Y., Wharram, B. L., Lee, S. K., Wickman, L., Goyal, M., Venkatareddy, M., Chang, J. W., Wiggins, J. E., Lienczewski, C., Kretzler, M., & Wiggins, R. C. (2009). Urine Podocyte mRNAs Mark Progression of Renal Disease. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.2007121328
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.